Alphabetical Listing of Primary Antibodies:
f
|
0-4
|
5-9
|
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
Alphabetical Listing of Proteins:
f
|
0-4
|
5-9
|
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
Peptides
|
Secondary Antibodies
|
ELISA Kits
FKHR [14E4] Antibody, Mouse Monoclonal Antibody
Catalog Number: 20-272-193282
Buy FKHR antibody -
Size:
0.2 mg ($590.00)
Related Product Names:
- FKHR antibody; FKHR; ForKHead in Rhabdomyosarcoma, Fork head, FKH R; FKHR [14E4]
- Mouse monoclonal antibody to human FKHR; 2308; FOXO1A; 136533; Q12778; FKH1; FKHR; FOXO1;; 2308; FOXO1A; 136533; Q12778; FKH1; FKHR; FOXO1;
- Gene Information -
Information in yellow represents specific gene information and does not necessarily represent specific product details. For more information please contact
sales@genwaybio.com
.
Gene Name:
FKHR
Gene Name Synonym:
ForKHead in Rhabdomyosarcoma, Fork head, FKH R
Gi #:
N/A
NCBI Acc #:
NP_002006.2
Swiss Prot Acc #:
Q12778
Length (aa):
N/A
Mol. Weight (Da):
69662
Chrom Location:
N/A
Clone:
14E4
Isotype:
IgG2b
Light chain:
kappa
Immunogen:
Amino acids 242-655 of FKHR expressed in E. coli.
Positive Control:
Cos 1 cells transfected with human FKHR
Target:
FKHR
Concentration:
1 mg/ml
Purification Note:
From hybridoma tissue culture supernatant
Storage Buffer:
Phosphate-buffered saline, pH 7.4, containing no preservatives
Application Note:
For WB: Use at a concentration of 0.1 - 2.0 µg/ml. Predicted molecular weight: 70 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher.
Source/Host:
Mouse
Purity/Purification:
Protein G Affinity Purified
Clonality:
Monoclonal
Crossreactivity:
Human- Not yet tested in other species
Format:
Liquid
Storage:
Keep as concentrated solution. Store at 4C short term. For extended storage aliquot and store at -20C or below. Avoid freeze-thaw cycles.
Shipping:
Products may be shipped on ice pack or dry ice.
APPLICATIONS for FKHR ANTIBODY:
WB: Tested
TESTING: (
secondary reagents
and
protocols
)
Not Available
FKHR ANTIBODY TARGET DESCRIPTION:
Synonym Names for FKHR antibody:
FKHR; ForKHead in Rhabdomyosarcoma, Fork head, FKH R; Mouse monoclonal antibody to human FKHR; 2308; FOXO1A; 136533; Q12778; FKH1; FKHR; FOXO1;; 2308; FOXO1A; 136533; Q12778; FKH1; FKHR; FOXO1;
FKHR-14E4 recognizes FKHR (ForKHead in Rhabdomyosarcoma), a 70a protein, which is one member in a subfamily of the forkhead homeotic gene family of transcription factors. Recent experiments have shown that this protein can act as either a coactivator or a corepressor of nuclear receptor activity. This action is mediated through the LXXLL motif found in the carboxyl terminal region of the FKHR protein.
Function:
Transcription factor.
Subunit:
Interacts with LRPPRC (By similarity).
Subcellular Location:
Cytoplasm. Nucleus. Note=Shuttles between cytoplasm and nucleus.
Tissue Specificity:
Ubiquitous.
Ptm:
Phosphorylated by AKT1; insulin-induced (By similarity). IGF1 rapidly induces phosphorylation of Ser-256, Thr-24, and Ser-319. Phosphorylation of Ser-256 decreases DNA-binding activity and promotes the phosphorylation of Thr-24, and Ser-319, permitting phosphorylation of Ser-322 and Ser-325, probably by CK1, leading to nuclear exclusion and loss of function. Phosphorylation of Ser-329 is independent of IGF1 and leads to reduced function. Phosphorylated upon DNA damage, probably by ATM or ATR.
Disease:
Chromosomal aberrations involving FOXO1 are a cause of rhabdomyosarcoma 2 (RMS2) [MIM:268220]; also known as alveolar rhabdomyosarcoma. Translocation (2;13)(q35;q14) with PAX3; translocation t(1;13)(p36;q14) with PAX7. The resulting protein is a transcriptional activator.
Similarity:
Contains 1 fork-head DNA-binding domain.
FKHR [14E4] reacts with human- not yet tested in other species .
OMIM:
136533; gene. [
NCBI
/
EBI
]
268220; phenotype. [
NCBI
/
EBI
]
Products similar to FKHR antibody:
IgG
FOXO1, IgG
FKHRL1 (Ab-253), IgG
FKHR (Ab-256), IgG
FOXO3A, IgG
FKHR [7H3], IgG
Peptide
FKHRL1 (Phospho-Ser253) Antibody Blocking Peptide, Peptide
FKHR (Phospho-Ser319) Antibody Blocking Peptide, Peptide
FKHR (Phospho-Ser256) Antibody Blocking Peptide, Peptide
PRODUCT INTERACTIONS:
FKHR [14E4]
interacts
with
Anti-Dihydrotestosterone, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Anti-Dihydrotestosterone, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Cell division control protein 2 homolog, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (cell division cycle 2. G1 to S and G2 to M), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Cdc2, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Cdc2, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 [A17], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 [Y100.4], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDK1 + CDK2 [AN21.2], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 [POH-1], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 [3E1.1], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Phospho-Thr161), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Phospho-Tyr15), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Ab-161), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Ab-15), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Phospho-Thr161) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 (Phospho-Tyr15) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Rabbit anti Cyclin cdc2 (p34), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Rabbit anti Cyclin cdk2, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Anti-cdc2 (p34), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Cdc2, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 phospho Y15 antibody, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
CDC2 [B322 (POH-1)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B401 (AER303)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B402 (AER304)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B403 (AER308)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B404 (AER310)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B405 (AER311)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B406 (AER314)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B407 (AER315)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B408 (AER317)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B409 (AER320)], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [B30.1], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [6F11], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser104), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser106), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser118), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser167), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Ab-104), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Ab-106), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Ab-118), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Ab-167), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser104) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser106) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser118) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor-alpha (Phospho-Ser167) Antibody Blocking Peptide, Peptide
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
Estrogen Receptor, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ERa Human, Protein
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ESTROGEN RECEPTOR ALPHA, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ESTROGEN RECEPTOR ALPHA, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha (ready-to-use), IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [6F11], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [1F3], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha [1F3], IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha, IgG
(GenWay Catalog #: 20-272-193282)
.
FKHR [14E4]
interacts
with
ER alpha, IgG
(GenWay Catalog #: 20-272-193282)
.
SUGGESTED ANITBODY REAGENTS
- GenWay has an extensive selection of reagents useful for antibody applications. Find blocking buffers, stop reagents, chemiluminescent substrates, diluents, Immunohistochemistry reagents & more.
Order Confirmation:
Sales order confirmations are sent out upon the receipt of all orders. Please contact GenWay if you do not receive a confirmation within 1 business day of submitting your order.
Precautions:
FKHR antibody is for in vitro research use only. Not for use in diagnostics or therapeutic procedures.
Important Notes:
During shipment, small volumes of FKHR antibody vial. For products with volumes of 200 µL or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. Actual concentration, volume and quantity will be printed on the vial's label. Please refer to the vials label for this information.
Copyright:
This GenWay TDS is copyrighted. This datasheet is produced based partially on data from Swiss-Prot/TrEMBL and NCBI. To better serve our clients with everything we know about FKHR antibody, all related information, articles, resources about FKHR antibody are being stored on our online database. Let us know if you have questions regarding this product.
Disclaimer:
For documents and software available from this server, GenWay neither warrants nor assumes any legal liability or responsibility for the accuracy, completeness or utility of any information, product or process disclosed.
GenWay is a Protein and Antibody Solutions Provider. Customer Satisfaction is Our Top Priority.
Thank you for visiting GenWay Biotech's Datasheet. GenWay is the world's leader in chicken, IgY antibody production, producing over 900 quality polyclonal IgY antibodies to date. From our unique recombinant protein production, utilizing a variety of protein expression systems, GenWay's polyclonal IgY antibodies incorporate more epitopes, increasing the success rate for ELISA, western blot, immunohistochemistry (IHC), immunocytochemistry (ICC), and many more immunoassays.
Exact |
Advanced Search
Specific Categories
Antibodies
Secondary Antibodies
Proteins
Custom Antibody
ELISA Kits
Reagents
Products by Pathway
Protein Expression
Cell Line Development
GenWay Biotech, Inc. 6777 Nancy Ridge Drive, San Diego, CA 92121
Tel:
(858)458-0866
Fax:
(858)458-0833
Email:
sales@genwaybio.com
www.genwaybio.com
©1998 - 2010 GenWay Biotech, Inc. - All Rights Reserved